Vimarsana
Biggest News Aggregation in the World

Page 24 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Pricing Program Today - Breaking & Trending Today

California Considers Bill to Protect 340B Covered Entities from PBM Discrimination | McDermott Will & Emery - Vimarsana News

California Considers Bill to Protect 340B Covered Entities from PBM Discrimination | McDermott Will & Emery

The California State Senate recently passed legislation that would prohibit pharmacy benefit managers (PBMs) from discriminating against entities participating in the 340B Drug Pricing...

CA Moves to Protect Drug Pricing Program Participants - Vimarsana News

CA Moves to Protect Drug Pricing Program Participants

The California State Senate recently passed legislation that would prohibit pharmacy benefit managers PBMs from discriminating against entities participating in the 340B Drug Pricing Program. Bill would prohibit PBMs from imposing requirements conditions or exclusions.

Thune, Stabenow, Capito, Baldwin, Moran, Cardin seek feedback on 340B drug discount program - Vimarsana News

Thune, Stabenow, Capito, Baldwin, Moran, Cardin seek feedback on 340B drug discount program

U.S. Sens. John Thune (R-S.D.), Debbie Stabenow (D-Mich.), Shelley Moore Capito (R-W.Va.), Tammy Baldwin (D-Wi...

Opioid settlement payouts: How much Chicago's getting | Crain's Chicago Business - Vimarsana News

Opioid settlement payouts: How much Chicago's getting | Crain's Chicago Business

Rep. Kelly wants answers on anti-abortion vandalism in Danville, rampant distrust of AI in health care and more in today's Health Pulse.

Report: Inaccurate Drug Discount Requests Reach Nearly $1B - Vimarsana News

Report: Inaccurate Drug Discount Requests Reach Nearly $1B

Kalderos identified nearly $1B in inaccurate drug discount requests from 2016-Q1 2023 on its drug discount management platform.